col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: International Journal of Drug Policy
  original article Date Title Authors   All Authors
1 [GO] 2022―Jan―25 Changes in retrospectively recalled alcohol use pre, during and post alcohol sales prohibition during COVID pandemic in Botswana J. Maphisa Maphisa, Kefentse Mosarwane
2 [GO] 2022―Jan―20 Methadone Exposures Reported to Poison Control Centers in the United States Following the COVID-19-Related Loosening of Federal Methadone Regulations Christopher Welsh, Suzanne Doyon, Katherine Hart
3 [GO] 2022―Jan―05 No party, no drugs? Use of stimulants, dissociative drugs, and GHB/GBL during the early COVID-19 pandemic1 Antonia Bendau, Leonard Viohl, Moritz Bruno Petzold, Jonas Helbig, Simon Reiche, Roman Marek, et al. (+10)
4 [GO] 2021―Dec―23 Evaluating how has care been affected by the Ontario COVID-19 Opioid Agonist Treatment Guidance: Patients’ and prescribers’ experiences with changes in unsupervised dosing Kim Corace, Kelly Suschinsky, Jennifer Wyman, Pamela Leece, Sue Cragg, Sarah Konefal, et al. (+4)
5 [GO] 2021―Dec―20 Treatment of Hepatitis C Virus among People Who Inject Drugs at a Syringe Service Program During the COVID-19 Response: the Potential Role of Telehealth, Medications for Opioid Use DIsorder and Minimal Demands on Patients Anishaa Sivakumar, Lynn Madden, Elizabeth DiDomizio, Anthony Eller, Merceditas Villanueva, Frederick L. Altice
7 [GO] 2021―Dec―08 Impacts of changes in alcohol consumption patterns during the first 2020 COVID-19 restrictions for people with and without mental health and neurodevelopmental conditions: A cross sectional study in 13 countries Emma L. Davies, Cheneal Puljevic, Gail Gilchrist, Laura Potts, Ahnjili Zhuparris, Larissa J. Maier, et al. (+3)
8 [GO] 2021―Dec―01 The COVID-19 Pandemic and the Health of People Who Use Illicit Opioids in New York City, the First 12 Months Alex S. Bennett, Tarlie Townsend, Luther Elliott
9 [GO] 2021―Nov―26 Experiences with take-home dosing in heroin-assisted treatment in Switzerland during the COVID-19 pandemic - is an update of legal restrictions warranted? Maximilian Meyer, Johannes Strasser, Patrick Köck, Marc Walter, Marc Vogel, Kenneth M. Dürsteler
10 [GO] 2021―Nov―19 Experiences with Substance Use Disorder Treatment During the COVID-19 Pandemic: Findings from a Multistate Survey Brendan Saloner, Noa Krawczyk, Keisha Solomon, Sean T. Allen, Miles Morris, Katherine Haney, Susan G. Sherman
11 [GO] 2021―Oct―29 Trends in cannabis use among U.S. adults amid the COVID-19 pandemic Savannah G. Brenneke, Courtney D. Nordeck, Kira E. Riehm, Ian Schmid, Kayla N. Tormohlen, Emily J. Smail, et al. (+4)
12 [GO] 2021―Sep―29 The success rate of online illicit drug transactions during a global pandemic Andréanne Bergeron, David Décary-Hétu, Luca Giommoni, Marie-Pier Villeneuve-Dubuc
13 [GO] 2021―Sep―20 Twitter Discourse on Nicotine as Potential Prophylactic or Therapeutic for COVID-19 Ramakanth Kavuluru, Jiho Noh, Shyanika W. Rose
14 [GO] 2021―Aug―04 Cannabis sales increases during COVID-19: Findings from Alaska, Colorado, Oregon, and Washington Gillian L. Schauer, Julia A. Dilley, Douglas R. Roehler, Thomas J. Sheehy, Jessica R. Filley, Sara Cooley Broschart, et al. (+4)
15 [GO] 2021―Aug―03 Using a “Big Events” framework to understand emergency department use among women experiencing homelessness or housing instability in San Francisco during the COVID-19 pandemic Elise D. Riley, Maria C. Raven, Samantha E. Dilworth, Carl Braun, Elizabeth Imbert, Kelly M. Doran
16 [GO] 2021―Jul―20 Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): a qualitative study of experiences of COVID-19 among people who inject drugs Joanna M. Kesten, Adam Holland, Myles-Jay Linton, Hannah Family, Jenny Scott, Jeremy Horwood, et al. (+6)
17 [GO] 2021―Jul―20 Changes in Characteristics of Drug Overdose Death Trends during the COVID-19 Pandemic Catherine DiGennaro, Gian-Gabriel P. Garcia, Erin J. Stringfellow, Sarah Wakeman, Mohammad S. Jalali
18 [GO] 2021―Jun―14 “I'm pretty sure it's either food poisoning or Covid-19”: Lived experience versus medical knowledge in diagnosing substance use problems David Frank
19 [GO] 2021―Jun―08 Lessons Learned Recruiting A Diverse Sample of Rural Study Participants During the COVID-19 Pandemic Nam Hyo Kim, NeCall Wilson, Trish Mashburn, Lauren Reist, Salisa C. Westrick, Kevin Look, et al. (+2)
20 [GO] 2021―May―14 Political Partisanship and Stigma Against People Who Use Drugs in Opinions About Allocating COVID-19 Prevention Resources to Vulnerable Populations Kristin E. Schneider, Deborah Wilson, Lauren Dayton, Erin M. Anderson Goodell, Carl A. Latkin
21 [GO] 2021―Apr―20 Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada Farihah Ali, Cayley Russell, Frishta Nafeh, Jürgen Rehm, Sean LeBlanc, Tara Elton-Marshall
22 [GO] 2021―Mar―20 Pathways between COVID-19 Public Health Responses and Increasing Overdose Risks: A Rapid Review and Conceptual Framework Tribesty Nguyen, Jane A. Buxton
23 [GO] 2021―Mar―06 A Free Mailed Naloxone Program in Philadelphia amidst the COVID-19 Pandemic Rachel French, Jamie Favaro, Shoshana V. Aronowitz
24 [GO] 2021―Mar―01 Multi-level drivers of tobacco use and purchasing behaviors during COVID-19 “lockdown”: A qualitative study in the United States Daniel P. Giovenco, Torra E. Spillane, Rachel M. Maggi, Esther Y. Lee, Morgan M. Philbin
25 [GO] 2021―Feb―07 “How will I get my next week's script?” Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic Noa Krawczyk, Amanda M. Bunting, David Frank, Joshua Arshonsky, Yuanqi Gu, Samuel R. Friedman, Marie A. Bragg
26 [GO] 2021―Jan―31 Drug-related violence: will COVID-19 drive better data for safer and more secure EU? Teodora Groshkova, Marieke Liem, Andrew Cunningham, Roumen Sedefov, Paul Griffiths
27 [GO] 2021―Jan―20 A rapid review of the impacts of "Big Events" on risks, harms, and service delivery among people who use drugs: Implications for responding to COVID-19. Camille Zolopa, Stine Hoj, Julie Bruneau, Julie-Soleil Meeson, Nanor Minoyan, Marie-France Raynault, et al. (+2)
28 [GO] 2021―Jan―14 COVID-19 and people who use drugs; Seizing opportunity in times of chaos Ernst WISSE, Naomi Burke-Shyne, Judy Chang, Mat Southwell
29 [GO] 2020―Dec―23 Evidence of Increased Fentanyl Use During the COVID-19 Pandemic Among Opioid Agonist Treatment Patients in Ontario, Canada Kristen A. Morin, Shreedhar Acharya, Joseph K. Eibl, David C. Marsh
30 [GO] 2020―Dec―10 Essential work, precarious labour: The need for safer and equitable harm reduction work in the era of COVID-19 Michelle Olding, Allison Barker, Ryan McNeil, Jade Boyd
31 [GO] 2020―Nov―24 Medication and substance use increases among people using cannabis medically during the COVID-19 pandemic Kevin F. Boehnke, Jenna McAfee, Joshua M. Ackerman, Daniel J. Kruger
32 [GO] 2020―Nov―20 Possibilities and pitfalls? Moderate drinking and alcohol abstinence at home since the COVID-19 lockdown Emily Nicholls, Dominic Conroy
33 [GO] 2020―Nov―09 COVID-19 and the health of people who use drugs: What is and what could be? Jason Grebely, Magdalena Cerdá, Tim Rhodes
34 [GO] 2020―Nov―07 Harm reduction in the time of COVID-19: Case study of homelessness and drug use in Dublin, Ireland Austin O'Carroll, Tony Duffin, John Collins
35 [GO] 2020―Oct―27 Supplying synthetic opioids during a pandemic: An early look at North America Bryce Pardo
36 [GO] 2020―Oct―19 Can google trends search inform us about the population response and public health impact of abrupt change in alcohol policy? - a case study from india during the covid-19 pandemic Abhishek Ghosh, Fazl e-Roub, Narayanan C Krishnan, Shinjini Choudhury, Aniruddha Basu
37 [GO] 2020―Oct―16 Understanding Challenges for Recovery Homes During COVID-19 Douglas L. Polcin, Elizabeth Mahoney, Friedner Wittman, Dave Sheridan, Amy A. Mericle
38 [GO] 2020―Aug―26 Virtual raves and happy hours during COVID-19: New drug use contexts for electronic dance music partygoers Joseph J. Palamar, Patricia Acosta
39 [GO] 2020―Aug―17 Coordination, cooperation, and creativity within harm reduction networks in Iran: COVID-19 prevention and control among people who use drugs Maryam Alavi, Amir Moghanibashi-Mansourieh, Seyed Ramin Radfar, Sepideh Alizadeh, Fatemeh Bahramabadian, Sara Esmizade, et al. (+3)
40 [GO] 2020―Aug―15 Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19 Corey S. Davis, Elizabeth A. Samuels
41 [GO] 2020―Aug―11 No “back to normal” after COVID-19 for our failed drug policies Pozo Brandon del, Leo Beletsky
42 [GO] 2020―Jul―31 No magic pocket: Buying and selling on drug cryptomarkets in response to the COVID-19 pandemic and social restrictions Monica J. Barratt, Judith Aldridge
43 [GO] 2020―Jul―30 Preliminary findings of the impact of COVID-19 on drugs crypto markets Andréanne Bergeron, David Décary-Hétu, Luca Giommoni
44 [GO] 2020―Jul―30 Care During COVID-19: Drug Use, Harm Reduction, and Intimacy During a Global Pandemic Allison Schlosser, Shana Harris
45 [GO] 2020―Jul―29 Drug use during a pandemic: Convergent risk of novel coronavirus and invasive bacterial and viral infections among people who use drugs Brendan P. Jacka, Emily Phipps, Brandon D.L. Marshall
46 [GO] 2020―Jul―27 Safer opioid distribution in response to the COVID-19 pandemic Mark Tyndall
47 [GO] 2020―Jul―21 Addressing co-occurring public health emergencies: The importance of naloxone distribution in the era of COVID-19 Alexandra B. Collins, Colleen Daley Ndoye, Diego Arene-Morely, Brandon D.L. Marshall
48 [GO] 2020―Jul―15 The impact of COVID-19 restrictions on needle and syringe programme provision and coverage in England Mark Whitfield, Howard Reed, Jane Webster, Vivian Hope
49 [GO] 2020―Jul―06 Isolating the isolated: Implications of COVID-19 quarantine measures on in-patient detoxification treatment for substance use disorders Paola Rosca, Barak Shapira, Yehuda Neumark
50 [GO] 2020―Jul―03 COVID-19 - Enacting a ‘new normal’ for people who use drugs Judy Chang, Jake Agliata, Mauro Guarinieri
51 [GO] 2020―Jul―03 Participation of the nursing workforce to address COVID-19 among people who use alcohol, tobacco, and drugs Vincent Guilamo-Ramos, Adam Benzekri, Marco Thimm-Kaiser, Marissa Abram, Holly Hagan
52 [GO] 2020―Jul―03 Why we should all be more careful in drawing conclusions about how COVID-19 is changing drug markets Luca Giommoni
53 [GO] 2020―Jul―02 The SARS-Cov-2 threat in Cracolândia, an open-air drug use scene in Brazil Felipe B. Arcadepani, Vitor S. Tardelli, Thiago M. Fidalgo
54 [GO] 2020―Jun―22 An urgent impetus for action: safe inhalation interventions to reduce COVID-19 transmission and fatality risk among people who smoke crack cocaine in the United Kingdom Magdalena Harris
55 [GO] 2020―Jun―12 Syringe Services Program (SSP) Operational Changes During the COVID-19 Global Outbreak Tyler S. Bartholomew, Nobuyo Nakamura, Lisa R. Metsch, Hansel E. Tookes
56 [GO] 2020―Jun―11 The Perfect Storm: COVID-19, mass incarceration and the opioid epidemic Trena I. Mukherjee, Nabila El-Bassel
57 [GO] 2020―Jun―03 Challenges of providing COVID-19 prevention services to homeless people who use drugs in Iran Abbas Deilamizade, Amir Moghanibashi-Mansourieh


Last change 2022―Jan―26 16:55:12 UTC

© Daten-Quadrat 2022       Done in 0.010 sec